Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▲ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 47 | 0 | 4 | 0 | €685.20 | €753.63 | 9.987% |
| Sanofi S.A. ADR | 11 | 1 | 0 | 0 | €44.60 | - | - |
| Vivoryon Therapeutics N.V. | 1 | 0 | 0 | 0 | €0.79 | - | - |
| Esperion Therapeutis.Inc. | 12 | 0 | 1 | 0 | €1.77 | €8.39 | 373.395% |
| Dr. Reddy's Laboratories Ltd. ADR | 5 | 1 | 1 | 0 | €68.50 | €73.92 | 7.912% |
| MorphoSys AG | 7 | 0 | 0 | 0 | €67.75 | €65.00 | -4.059% |
| Eledon Pharmaceuticals Inc. | 4 | 0 | 0 | 0 | €1.82 | €12.09 | 564.253% |
| Edap Tms S.A. ADR | 3 | 1 | 1 | 0 | €6.80 | €14.79 | 117.529% |
| AstraZeneca plc | 1 | 0 | 0 | 0 | €139.95 | €165.00 | 17.899% |
| Drägerwerk AG & Co. KGaA VZO | 3 | 0 | 1 | 0 | €48.90 | €57.50 | 17.587% |
| Molina Healthcare | 11 | 1 | 1 | 1 | €319.90 | €359.93 | 12.515% |
| Align Technology | 16 | 2 | 4 | 0 | €288.90 | €345.95 | 19.747% |
| Bayer AG | 15 | 1 | 0 | 0 | €27.48 | €50.00 | 81.984% |
| Stratec SE | 2 | 0 | 0 | 0 | €42.10 | - | - |
| Knight Therapeutics | 1 | 0 | 0 | 0 | €3.78 | €10.00 | 164.550% |
| Staar Surgical Co. | 11 | 1 | 4 | 0 | €43.86 | €49.02 | 11.760% |
| Adverum Biotechnologies Inc. | 4 | 1 | 0 | 0 | €1.38 | €3.70 | 168.304% |
| ProQR Therapeutics N.V. | 6 | 0 | 1 | 0 | €1.89 | €2.81 | 48.695% |
| R1 RCM Inc. | 19 | 0 | 2 | 0 | €10.70 | €17.21 | 60.865% |
| iRhythm Technologies Inc | 10 | 0 | 0 | 0 | €108.00 | €122.84 | 13.740% |
| Pro-Dex Inc. | 16 | 0 | 0 | 0 | €16.70 | - | - |
| Axsome Therapeutics Inc | 2 | 0 | 0 | 0 | €67.06 | €100.00 | 49.120% |
| Rhythm Pharmaceuticals | 14 | 0 | 2 | 0 | €36.60 | €46.08 | 25.908% |
| Motus GI Holdings Inc. | 2 | 0 | 0 | 0 | €0.43 | €2.33 | 443.991% |
| Nektar Therapeutics | 3 | 1 | 1 | 0 | €1.23 | €3.70 | 201.058% |